In June 2020, BSV formed a strategic alliance with LaVoieHealthScience in order to enhance BSV's capabilities to communicate value. <read more here>                     In May 2020, BSV entered into a strategic alliance with FCF Fox Corporate Finance to support funding activities. <read more here>                    
                           COVID-19 Portal               Home      About      Team      Clients      Publications      Downloads      News      Career      Contact

  Bioscience Valuation's unique approach to portfolio management clearly enhanced the value of our R&D pipeline.

Prof. Dr. Klaus Nickisch, CSO Evestra Inc., formerly Head of Project Management at Bayer Schering Pharma AG


Core Services
  Financial Valuation
  Commercial Assessment &

  R&D Risk Analysis &
Productivity Increase

  Portfolio Management
  Investment Decisions
  Partnering / Licensing
  Corporate Finance / M&A

Special Expertise
  Economic Modeling
of Healthcare Systems

  Assessing the Economics
of Personalized Medicine

Comprehensive Support
  Corporate Partnership Program

  Market Model
  R&D Risk Model
  Valuation Model

Bioscience Corporate Partnership Program

Bioscience Valuation's Corporate Partnership Program offers returning clients, or new clients who plan to engage BSV repeatedly, cost-efficient access to Bioscience Valuation's expertise and knowledge. As 'premium clients' partners enjoy full support with a short turnaround time and immediate availability of BSV's staff. In short, advantages for clients who join our partnership program are:
  • fast access to BSV's expertise and knowledge,
  • constant, virtually unlimited support throughout a year,
  • premium service covering all our offerings at reduced cost,
  • free training of clients' personnel in our assessment methodologies.

Please contact us for more information.

This website uses cookies to ensure you get the best experience on our website.
Privacy Policy